Branding, naming, and domain names are essential considerations for biotechnology companies as they establish their presence in the market. A strong brand identity can help these companies stand out in a crowded industry and communicate their unique value proposition to potential customers and investors.
What is Prilenia? Prilenia is a biotechnology services provider. What does Prilenia do? The company develops treatments for neurodegenerative and neurodevelopmental disorders. Who owns Prilenia? Michael R Hayden founded Prilenia in 2018. How much has Prilenia raised? The company picked up $43 million in a Series B funding round that brings the company’s total financing […]
Click Therapeutics is a regulated Software as a Medical Device (SaMD)-focused biotechnology company. They raised a total of $911 million.
Previous page Next page